Amarendra Neppalli to Cell- and Tissue-Based Therapy
This is a "connection" page, showing publications Amarendra Neppalli has written about Cell- and Tissue-Based Therapy.
Connection Strength
0.046
-
Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2022 05; 22(5):326-335.
Score: 0.046